Neuromuscular Blockade for Post-Cardiac Arrest Care

PHASE2CompletedINTERVENTIONAL
Enrollment

83

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

May 29, 2019

Study Completion Date

May 29, 2019

Conditions
Cardiac Arrest
Interventions
DRUG

Rocuronium

Neuromuscular Blockade

DRUG

Normal Saline

Normal Saline

Trial Locations (5)

15213

University of Pittsburgh, Pittsburgh

35294

Michael Kurz, Birmingham

48073

Robert Swor, Royal Oak

02215

Beth Israel Deaconess Medical Center, Boston

Brigham and Women's Hospital, Boston

All Listed Sponsors
collaborator

University of Pittsburgh Medical Center

OTHER

collaborator

Brigham and Women's Hospital

OTHER

collaborator

University of Alabama at Birmingham

OTHER

collaborator

Beaumont Hospital

OTHER

lead

Beth Israel Deaconess Medical Center

OTHER

NCT02260258 - Neuromuscular Blockade for Post-Cardiac Arrest Care | Biotech Hunter | Biotech Hunter